Fig. 2From: Clinicopathological and prognostic significance of FOXP3+ tumor infiltrating lymphocytes in patients with breast cancer: a meta-analysisEvaluated hazard ratios (HR) summary for RFS (a) and OS (b). a HR for recurrence-free survival (RFS) with FOXP3+ TILs detection. b HR for overall survival (OS) with FOXP3+ TILs detectionBack to article page